Company profile
Choom Holdings Inc.
OTC: CHOOF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#570 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 39
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), Piotroski F · ↓ market scale, balance-sheet leverage
Methodology →Revenue TTM
$15.2M
Rev growth YoY (TTM)
+11.4%
Net income (FY)
-$16.9M
Employees
40
as of 2026-08-30
Market cap
$4.7k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$17.2M22.0M CAD2021
Net income-$16.9M-21.6M CAD2021
Operating income-$3.8M-4.9M CAD2021
Total assets$21.1M26.2M CAD2021
Liabilities$30.1M37.4M CAD2021
Equity-$9.0M-11.2M CAD2021
Revenue trend
FY2017 – FY2021 · USD
FY17
FY18
FY19
FY20
FY21
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Choom Holdings Inc.’s revenue?
Choom Holdings Inc. booked $17.2M in FY2021 revenue, growing 214% year over year — faster than 90% of Healthcare companies we track, at a -98.1% net margin.
Peers · Healthcare
Micron Solutions, Inc.——Vivos Therapeutics, Inc.38DClever Leaves Holdings Inc.——Veru Inc.49DPelthos Therapeutics Inc.37DIsodiol International Inc.——Key facts
CEOTerese Joanne Gieselman
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: CHOOF
Employees40
IPO date2013-02-15
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.